Dr. Andrew Feilden joined Bicycle Therapeutics as CMC Director of Analytical Science, where he is responsible for regulatory testing.
He has previously held leadership positions at CROs specialising in extractable and leachable testing. He is a technical expert in the field of E&L testing, having been involved in the field of E&L for over 20 years. At Hall he undertakes Commercial, Operational and technical thought leadership activities.
Andrew has presented on the field of extractables and leachables in over 17 countries worldwide. He has written a number of papers and publications and is the inventor of 2 patents.
He has a degree and D Phil from the university of York, is a Fellow of the Royal Society of Chemistry and was a Scientific Advisor to IPAC-RS and ex-co-chair of ELSIE.